Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
91.97 USD | -0.09% | +1.01% | -3.25% |
Apr. 24 | Earnings Flash (AMED) AMEDISYS Reports Q1 EPS $1.03 | MT |
Apr. 24 | Amedisys, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 2.33B | Sales 2025 * | 2.5B | Capitalization | 3.01B |
---|---|---|---|---|---|
Net income 2024 * | 118M | Net income 2025 * | 156M | EV / Sales 2024 * | 1.42 x |
Net Debt 2024 * | 305M | Net Debt 2025 * | 311M | EV / Sales 2025 * | 1.33 x |
P/E ratio 2024 * |
25.9
x | P/E ratio 2025 * |
19.7
x | Employees | 19,000 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.72% |
1 day | -0.09% | ||
1 week | +1.01% | ||
Current month | -0.09% | ||
1 month | -0.49% | ||
3 months | -2.56% | ||
6 months | +0.58% | ||
Current year | -3.25% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 23-04-09 | |
Scott Ginn
DFI | Director of Finance/CFO | 55 | 17-01-31 |
Paul Kusserow
CHM | Chairman | 62 | 14-12-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 70 | 15-04-21 | |
Molly Joel Coye
BRD | Director/Board Member | 76 | 19-10-31 |
Vickie Capps
BRD | Director/Board Member | 62 | 19-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.18% | 8 M€ | +2.44% | ||
0.83% | 2 M€ | +6.77% | ||
0.24% | 509 M€ | -.--% | ||
0.17% | 45 M€ | -0.69% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 91.89 | -0.17% | 221,968 |
24-04-30 | 92.05 | +0.23% | 222,058 |
24-04-29 | 91.84 | +0.05% | 235,097 |
24-04-26 | 91.79 | +0.69% | 144,548 |
24-04-25 | 91.16 | +0.12% | 236,321 |
Delayed Quote Nasdaq, May 01, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.25% | 3.01B | |
0.00% | 1.83B | |
+52.73% | 628M | |
-1.64% | 506M | |
-39.36% | 345M | |
-32.84% | 143M | |
-12.24% | 140M | |
+1.92% | 70.32M |
- Stock Market
- Equities
- AMED Stock